Drug & medication recalls Moderate risk

Mylan Pharmaceuticals Inc. recalls Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23…

Recall date
July 25, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-1075-2018
FDA classification
Class II
Brand / firm
Mylan Pharmaceuticals Inc.
Sold / distributed
U.S. Nationwide

Why it was recalled

Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

Get recall alerts

Free email alert whenever Mylan Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Mylan Pharmaceuticals Inc.